Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07838779 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An OLIP Study (Open Label Individual Patient) of Nusinersen in a Participant With Spinal Muscular Atrophy Who Previously Participated in an Investigational Study With Nusinersen

Name: An OLIP Study (Open Label Individual Patient) of Nusinersen in a Participant With Spinal Muscular Atrophy Who Previously Participated in an Investigational Study With Nusinersen — clinical trial record (NCT07838779)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhaseNot applicable

SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Started2026-09-17

View on ClinicalTrials.gov ↗

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

155 trials monitored

See 11 trials at risk

Spinal Muscular Atrophy

123 trials monitored

See 4 trials at risk

This study is an open label individual patient study of the drug Nusinsersen.

Trial Details

NCT Number	NCT07838779
Lead Sponsor	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions	SMA - Spinal Muscular Atrophy
Enrollment	1 participants
Start Date	2026-09-17
Primary Completion	2028-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-09-24